CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
 
 
 
 
 
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group plc is a United Kingdom-based medical devices company in the field of regenerative medicine. The Company is engaged in the development of regenerative products to make replacement body parts using biological (human & animal) materials, using platform technologies in the field of tissues engineering and regenerative medicine. The Company has developed decellularisation (dCELL) technology, which removes DNA and other cellular material from tissue leaving an acellular scaffold which is not rejected by the patient's body. The applications of dCELL address critical clinical needs such as wound care, heart valve replacement and knee repair. The company has developed DermaPure, a decellularized human dermis product, which replaces human dermis with human dermis, to most closely approximate the structure and function of the native tissue it is replacing.

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (5/15/2015): 20.25p
(Figures in Pounds Sterling)
1 Week -2.4%   13 Weeks 35.0%  
4 Weeks -1.2%   52 Weeks -17.3%  
 
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 100,000
(Year Ending Jan 2016).
Employees: 60
  Currency: Pounds Sterling Market Cap: 153,829,751
  Fiscal Yr Ends: January Shares Outstanding: 759,653,093
  Share Type: Ordinary Closely Held Shares: 256,452,470
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.